Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FUTIBATINIB vs GABAPENTIN ENACARBIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FUTIBATINIB vs GABAPENTIN ENACARBIL: Safety Overview

Metric FUTIBATINIB GABAPENTIN ENACARBIL
Total FAERS Reports 161 1,833
Deaths Reported 38 649
Death Rate 23.6% 35.4%
Hospitalizations 60 237
Average Patient Age 61.8 yrs 54.6 yrs
% Female Patients 51.3% 61.5%
FDA Approval Date Jul 28, 2025 Apr 6, 2011
Manufacturer TAIHO PHARMACEUTICAL CO., LTD. Azurity Pharmaceuticals, Inc. (former...
Route N/A ORAL
Marketing Status Prescription Prescription